$1.17
-0.025-2.10%
Last update: Jun 3, 3:31 PM
BioXcel Therapeutics Inc Earnings Estimates
BTAINASDAQ
BioXcel Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:BTAI
BioXcel Therapeutics (BTAI) is scheduled to report Q2 earnings on August 11, 2026. Analysts estimate EPS of $-0.56 and quarterly revenue of $203.41K.
In the most recent quarter (Q1), BioXcel Therapeutics reported EPS of $-0.54, missing estimates of $-0.51 by 0.06%. Revenue came in at $206.00K, missing the estimate of $363.19K by 0.43%.
BioXcel Therapeutics has missed EPS estimates in 4 consecutive quarters.
Over the last 4 quarters, BioXcel Therapeutics has averaged an EPS surprise of 0.26% and a revenue surprise of 0.55%.
Earnings Date
Aug 11
EPS Estimate
$-0.560
Quarterly Revenue Estimate
$203.41K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$680.00K
BioXcel Therapeutics Earnings History
Analyze the earnings history of BioXcel Therapeutics using advanced sorting and filters.
Loading calendar...
BioXcel Therapeutics (BTAI) Earnings Per Share
The chart below shows BioXcel Therapeutics's reported EPS compared to analyst estimates over recent quarters.
BioXcel Therapeutics (BTAI) Revenue
The chart below shows BioXcel Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is BioXcel Therapeutics (NASDAQ:BTAI) reporting earnings?
BioXcel Therapeutics (BTAI) is scheduled to report earnings on August 11, 2026. The last reported earnings were for reported on May 15, 2026 for Q1.
What were the latest earnings per share (EPS) for BioXcel Therapeutics (NASDAQ:BTAI)?
The Actual EPS was $-0.54, which missed the estimate of $-0.51.
What were BioXcel Therapeutics’s (NASDAQ:BTAI) revenues?
The Actual Revenue was $206.00K, which missed the estimate of $363.19K.
